(NewsNation) — Patients who took the weight-loss drug Wegovy showed significantly reduced heart risk in addition to maintaining weight loss, according to the results from Novo Nordisk's longest clinical trial. In addition to weight loss, the 17,604-patient trial, called Select, tested Wegovy's heart-protective benefits for overweight and obese patients who had pre-existing heart disease but not diabetes. Results showed that patients lost an average of nearly 10% of their total body weight after 65 weeks on Wegovy. Novo Nordisk stated that the weight loss percentage remained relatively consistent year after year until about four years when the weight loss reached 10.2%. Participa
Hence then, the article about wegovy may help with heart issues analysis was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Wegovy may help with heart issues: Analysis )